Cost-effectiveness of current and optimal treatment for schizophrenia

被引:64
作者
Andrews, G
Sanderson, K
Corry, J
Issakidis, C
Lapsley, H
机构
[1] Univ New S Wales, St Vincents Hosp, Sch Psychiat, World Hlth Org,Collaborating Ctr Evidence Mental, Sydney, NSW, Australia
[2] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia
关键词
D O I
10.1192/bjp.183.5.427
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background This paper is part of a project to identify the proportion of the burden of each mental disorder averted by current and optimal interventions, and the cost-effectiveness of both. Aims To use epidemiological data on schizophrenia to model the cost-effectiveness of current and optimal treatment. Method Calculate the burden of schizophrenia in the years lived with disability (YLD) component of disability-adjusted life-years lost, the proportion averted by current interventions, the proportion that could be averted by optimal treatment and the cost-effectiveness of both. Results Current interventions avert some 13% of the burden, whereas 22% could be averted by optimal treatment. Current interventions cost about AUS$200 000 per YLD averted, whereas optimal treatment at a similar cost could increase the number of YLDs averted by two-thirds. Even so, the majority of the burden of schizophrenia remains unavertable. Conclusions Optimal treatment is affordable within the present budget and should be implemented. Declaration of interest None.
引用
收藏
页码:427 / 435
页数:9
相关论文
共 38 条
  • [21] Link B G., 1980, Mental illness in the United States: Epidemiological estimates
  • [22] MANDERSCHEID RW, 1993, ARCH GEN PSYCHIAT, V50, P108
  • [23] Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study
    Marshall, T
    Rouse, A
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7357): : 197 - 199
  • [24] When is it cost-effective to change the behavior of health professionals?
    Mason, J
    Freemantle, N
    Nazareth, I
    Eccles, M
    Haines, A
    Drummond, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (23): : 2988 - 2992
  • [25] Early detection and intervention with schizophrenia: Rationale
    McGlashan, TH
    Johannessen, JO
    [J]. SCHIZOPHRENIA BULLETIN, 1996, 22 (02) : 201 - 222
  • [26] A national burden of disease calculation: Dutch disability-adjusted life-years
    Melse, JM
    Essink-Bot, ML
    Kramers, PGN
    Hoeymans, N
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (08) : 1241 - 1247
  • [27] A comparison of guidelines for the treatment of schizophrenia
    Milner, KK
    Valenstein, M
    [J]. PSYCHIATRIC SERVICES, 2002, 53 (07) : 888 - 890
  • [28] Role of psychosocial treatments in management of schizophrenia: A meta-analytic review of controlled outcome studies
    Mojtabai, R
    Nicholson, RA
    Carpenter, BN
    [J]. SCHIZOPHRENIA BULLETIN, 1998, 24 (04) : 569 - 587
  • [29] Public spending on health care: how are different criteria related?
    Musgrove, P
    [J]. HEALTH POLICY, 1999, 47 (03) : 207 - 223
  • [30] NATHAN PE, 1996, GUIDE TREATMENTS WOR